Agree with those comments
With gross margins heading to 60%, CMP is an exceedingly profitable company, it just needs the momentum in sales built up over the last couple of years to continue.
Per their guidance, they will do $4m to $5m EBITDA, that is AFTER expensing over $6m in R&D, so potentially $12m EBITDA pre R&D for FY15.
They have been consistently committing approx. 20% of revenues to R&D (twice the industry average). The result of all this R&D being that they are now in the strange situation that they have too many products coming through development than they know what to do with / how to commercialise.
Very much like WRR in that once the main seller has gone, the strong numbers mean that something has to give.
- Forums
- ASX - By Stock
- CMP
- unintended asymmetric information
CMP
compumedics limited
Add to My Watchlist
1.79%
!
28.5¢

unintended asymmetric information, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $54.78M |
Open | High | Low | Value | Volume |
28.0¢ | 28.5¢ | 28.0¢ | $1.46K | 5.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19300 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 20999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19300 | 0.285 |
1 | 8410 | 0.280 |
1 | 25000 | 0.270 |
1 | 5000 | 0.265 |
1 | 70000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 20999 | 1 |
0.310 | 11560 | 2 |
0.325 | 2000 | 1 |
0.330 | 41875 | 3 |
0.340 | 13323 | 2 |
Last trade - 14.20pm 21/07/2025 (20 minute delay) ? |
Featured News
CMP (ASX) Chart |